{"id":"NCT05591755","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis","officialTitle":"Evaluation of the Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to Its Components and Vehicle in an Allergen BioCubeÂ® in Subjects With Seasonal Allergic Conjunctivitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-11-18","primaryCompletion":"2023-08-09","completion":"2023-08-09","firstPosted":"2022-10-24","resultsPosted":"2025-07-01","lastUpdate":"2025-07-01"},"enrollment":229,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution","otherNames":[]},{"type":"DRUG","name":"Ketotifen fumarate ophthalmic solution 0.035%","otherNames":[]},{"type":"DRUG","name":"Brimonidine tartrate ophthalmic solution 0.025%","otherNames":[]},{"type":"DRUG","name":"Experimental: Vehicle ophthalmic solution","otherNames":[]}],"arms":[{"label":"Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution","type":"EXPERIMENTAL"},{"label":"Ketotifen fumarate ophthalmic solution 0.035%","type":"EXPERIMENTAL"},{"label":"Brimonidine tartrate ophthalmic solution 0.025%","type":"EXPERIMENTAL"},{"label":"Vehicle ophthalmic solution","type":"EXPERIMENTAL"}],"summary":"To evaluate the efficacy of Combo compared to its individual components and compared to vehicle in a population of subjects with seasonal allergic conjunctivitis.","primaryOutcome":{"measure":"Ocular Itching Symptom Score","timeFrame":"Assessed up to 480 minutes post-instillation of assigned IP","effectByArm":[{"arm":"Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution","deltaMin":0.175,"sd":0.6031},{"arm":"Ketotifen Fumarate Ophthalmic Solution 0.035%","deltaMin":0.085,"sd":0.3136},{"arm":"Brimonidine Tartrate Ophthalmic Solution 0.025%","deltaMin":0.267,"sd":0.7549},{"arm":"Vehicle Ophthalmic Solution","deltaMin":0.098,"sd":0.3493}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":57},"commonTop":["Visual acuity reduced","Ocular hyperaemia","Conjunctival oedema","Eyelid exfoliation","Erythema of eyelid"]}}